A new coumarin derivative, 4-acetatecoumarin, with antifungal activity and association study against Aspergillus spp.

AUTOR(ES)

Guerra, Felipe Q.S., Araújo, Rodrigo S.A., Sousa, Janiere P., Silva, Viviane A., Pereira, Fillipe O., Mendonça-Junior, Francisco J.B., Barbosa-Filho, José M., Pereira, Julio Abrantes, Lima, Edeltrudes O.

FONTE

Braz. J. Microbiol.

DATA DE PUBLICAÇÃO

2018-06

RESUMO

Abstract Fungal infections have become a concern for health professionals, and the emergence of resistant strains has been reported for all known classes of antifungal drugs. Among the fungi causing disease, we highlight those that belong to the genus Aspergillus. For these reasons, the search for new antifungals is important. This study examines the effects of a coumarin derivative, 4-acetatecoumarin (Cou-UMB16) both alone and together with antifungal drugs, and its mode of action against Aspergillus spp. Cou-UMB16 was tested to evaluate its effects on mycelia growth, and germination of Aspergillus spp. fungal conidia. We investigated its possible action on cell walls, on the cell membrane, and also the capacity of this coumarin derivative to enhance the activity of antifungal drugs. Our results suggest that Cou-UMB16 inhibits Aspergillus spp. virulence factors (mycelia growth and germination of conidia) and affects the structure of the fungal cell wall. When applying Cou-UMB16 in combination with azoles, both synergistic and additive effects were observed. This study concludes that Cou-UMB16 inhibits mycelial growth and spore germination, and that the activity is due to its action on the fungal cell wall, and that Cou-UMB16 could act as an antifungal modifier.

Documentos Relacionados

• Minimal inhibitory concentrations of lucknomycin, a new polyenic derivative, for Candida and Aspergillus spp.
• Activity of SM-4470, a new imidazole derivative, against experimental fungal infections.
• Esculetin, a coumarin derivative, exerts in vitro and in vivo antiproliferative activity against hepatocellular carcinoma by initiating a mitochondrial-dependent apoptosis pathway
• In Vitro Activity of the Echinocandin Antifungal Agent LY303,366 in Comparison with Itraconazole and Amphotericin B against Aspergillus spp.
• In vitro antifungal and fungicidal spectra of a new pradimicin derivative, BMS-181184.